Literature DB >> 35314461

A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group.

Michele Bartoletti1, Alice Bergamini2, Gaia Giannone3,4, Camilla Nero5, Lucia Musacchio5, Alberto Farolfi6, Anna Passarelli7, Elisabetta Kuhn8,9, Daniele Castaldo10, Valentina Lombardo11, Teresa Di Palma12, Domenica Lorusso5,13, Fabio Puglisi1,14, Ugo De Giorgi6, Giorgio Valabrega3, Clorinda Schettino15, Giovanni Scambia5,13, Ettore Capoluongo16, Sandro Pignata17.   

Abstract

Entities:  

Keywords:  miscellaneous

Year:  2022        PMID： 35314461     DOI： 10.1136/ijgc-2022-003425

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


× No keyword cloud information.
  1 in total

1.  Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.

Authors:  Gennaro Ciliberto; Marco Canfora; Irene Terrenato; Chiara Agnoletto; Francesco Agustoni; Loredana Amoroso; Gustavo Baldassarre; Giuseppe Curigliano; Angelo Delmonte; Antonella De Luca; Michelangelo Fiorentino; Vanesa Gregorc; Toni Ibrahim; Chiara Lazzari; Angela Mastronuzzi; Paolo Pronzato; Armando Santoro; Giovanni Scambia; Stefania Tommasi; Andrea Vingiani; Patrizio Giacomini; Ruggero De Maria
Journal:  J Exp Clin Cancer Res       Date:  2022-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.